News

ADHD Med Recalled

09/14/2016

The US Food and Drug Administration (FDA) announced the recall of dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate tablets (mixed salts of a single entity amphetamine product).

What prompted the Class II recall? Amerisource Health Services initiated the recall due to a packaging issue. The blister packs may contain more than one tablet, according to the FDA’s Enforcement Report.

__________________________________________________________________________________________________________________________________________________________________________

The impacted lots are listed below.

Presentation	Lot	Expiration	Blister NDC
5 mg	163220	October 31, 2017	68084-874-95
5 mg	164194	November 20, 2017	68084-874-95
10 mg	150130	October 31, 2016	68084-936-95
10 mg	161296	August 31, 2017	68084-936-95
15 mg	150950	March 31, 2017	60687-133-95
15 mg	154813	May 31, 2017	60687-133-95
20 mg	162276	September 30, 2017	68084-943-95
30 mg	162278	October 31, 2017	60687-154-95
10 mg	152254	December 31, 2016	68084-815-95
10 mg	152324	March 31, 2017	68084-815-95
10 mg	154833	May 31, 2017	68084-815-95
10 mg	162406	December 31, 2017	68084-815-95
15 mg	162489	September 30, 2017	68084-898-33
15 mg	162910	October 31, 2017	68084-898-33
20 mg	152325	December 31, 2016	68084-832-95
20 mg	154834	May 31, 2017	68084-832-95
25 mg	162490	September 30, 2017	68084-909-33
30 mg	152418	December 31, 2016	68084-887-33
30 mg	153544	March 31, 2017	68084-887-33
30 mg	154835	May 31, 2017	68084-887-33

--Stephanie Vaccaro

Reference:

US Food and Drug Administration. FDA Enforcement Report – Week of September 14, 2016. www.fda.gov . Accessed September 15, 2016.

ADHD Med Recalled

Subscribe Today

HMP Global Products

Events